Bioimpedance: A Tool for Screening Oral Cancer - A Systematic Review.

Pub Date : 2023-04-01 Epub Date: 2023-06-30 DOI:10.4103/ccd.ccd_195_23
Vaibhav Gupta, Usha Agrawal, Poonam Goel
{"title":"Bioimpedance: A Tool for Screening Oral Cancer - A Systematic Review.","authors":"Vaibhav Gupta,&nbsp;Usha Agrawal,&nbsp;Poonam Goel","doi":"10.4103/ccd.ccd_195_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The successful management of cancer depends on proper screening and treatment methods. Bioimpedance spectroscopy (BIS) is an established technique in detecting breast cancer, cervical cancer, and prostate cancer. This systematic review sought to investigate the current evidence regarding the clinical application of bioimpedance in the detection of oral squamous cell carcinoma and oral potentially malignant disorders.</p><p><strong>Study design: </strong>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed to perform this review. Electronic databases such as PubMed, MEDLINE, Embase, EBSCOhost, and Google Scholar were searched till March 2022. Articles published in the English medical literature on human participants report on the application of BIS in the screening of precancerous and cancerous lesions. The primary endpoint was defined as the ability to differentiate between normal and cancerous tissue.</p><p><strong>Results: </strong>A total of 6754 articles were identified; of which 481 were eligible for inclusion. Only five articles met the eligibility criteria and were included in the study. Qualitative analysis for each study was done to assess the data provided. All the studies demonstrated a significant divergence in BIS metrics between cancerous and normal tissue at 20 Hz and 50 KHz.</p><p><strong>Conclusion: </strong>Bioimpedance appears to be a promising novel tool for the detection of various malignancies which can be used in community screening due to its noninvasiveness and portability.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/c8/CCD-14-91.PMC10399808.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ccd.ccd_195_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The successful management of cancer depends on proper screening and treatment methods. Bioimpedance spectroscopy (BIS) is an established technique in detecting breast cancer, cervical cancer, and prostate cancer. This systematic review sought to investigate the current evidence regarding the clinical application of bioimpedance in the detection of oral squamous cell carcinoma and oral potentially malignant disorders.

Study design: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed to perform this review. Electronic databases such as PubMed, MEDLINE, Embase, EBSCOhost, and Google Scholar were searched till March 2022. Articles published in the English medical literature on human participants report on the application of BIS in the screening of precancerous and cancerous lesions. The primary endpoint was defined as the ability to differentiate between normal and cancerous tissue.

Results: A total of 6754 articles were identified; of which 481 were eligible for inclusion. Only five articles met the eligibility criteria and were included in the study. Qualitative analysis for each study was done to assess the data provided. All the studies demonstrated a significant divergence in BIS metrics between cancerous and normal tissue at 20 Hz and 50 KHz.

Conclusion: Bioimpedance appears to be a promising novel tool for the detection of various malignancies which can be used in community screening due to its noninvasiveness and portability.

Abstract Image

Abstract Image

Abstract Image

分享
查看原文
生物阻抗:筛查口腔癌症的工具-系统综述。
目的:癌症的成功治疗取决于正确的筛查和治疗方法。生物阻抗谱(BIS)是一种已建立的检测乳腺癌症、癌症和癌症的技术。本系统综述旨在研究生物阻抗在口腔鳞状细胞癌和口腔潜在恶性疾病检测中的临床应用的最新证据。研究设计:遵循系统评价的首选报告项目和荟萃分析指南进行本次评价。PubMed、MEDLINE、Embase、EBSCOhost和Google Scholar等电子数据库被搜索至2022年3月。发表在英国医学文献中的关于人类参与者的文章报道了BIS在癌前和癌性病变筛查中的应用。主要终点被定义为区分正常组织和癌组织的能力。结果:共鉴定出6754篇文章;其中481人符合入选条件。只有五篇文章符合资格标准并被纳入研究。对每项研究进行定性分析,以评估所提供的数据。所有研究都表明,在20 Hz和50 KHz下,癌组织和正常组织的BIS指标存在显著差异。结论:生物阻抗是一种很有前途的检测各种恶性肿瘤的新工具,由于其无侵袭性和便携性,可用于社区筛查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信